Evidence map›Paper›PMID 39455824›Full record

ArticleCommunications biology2024

A conserved Plasmodium nuclear protein is critical for late liver stage development.

Debashree Goswami, Silvia A Arredondo, William Betz, Janna Armstrong, Sudhir Kumar, Gigliola Zanghi, Hardik Patel, Nelly Camargo, Kenza M Z Oualim, Annette M Seilie and 4 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Debashree GoswamiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. debashree.goswami@seattlechildrens.org.ORCID 0000-0001-5878-0482
Silvia A ArredondoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
William BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Janna ArmstrongCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Sudhir KumarCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID 0000-0002-2847-393X
Gigliola ZanghiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Hardik PatelCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID 0000-0003-0716-4510
Nelly CamargoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Kenza M Z OualimCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Annette M SeilieDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Sophia SchneiderCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Sean C MurphyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. stefan.kappe@seattlechildrens.org.ORCID 0000-0003-1540-1731
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. ashley.vaughan@seattlechildrens.org.ORCID 0000-0001-5815-756X

Funding

Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccinesU01AI155335 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KAPPE, STEFAN HI · 2021 to 2025
$6.3M
Engineering of genetically attenuated pre-erythrocytic Plasmodium parasites for cross-stage protective immunityR01AI125706 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KAPPE, STEFAN HI · 2016 to 2020
$2.3M
NIAID NIH HHS R01 AI125706NIAID NIH HHS U01 AI155335
6 · The paper itself

Abstract

Malaria, caused by Plasmodium parasites, imposes a significant health burden and live-attenuated parasites are being pursued as vaccines. Here, we report on the creation of a genetically attenuated parasite by the deletion of Plasmodium LINUP, encoding a liver stage nuclear protein. In the rodent parasite Plasmodium yoelii, LINUP expression was restricted to liver stage nuclei after the onset of liver stage schizogony. Compared to wildtype P. yoelii, P. yoelii LINUP gene deletion parasites (linup

Indexed as

LiverMalariaPlasmodium yoeliiProtozoan ProteinsAnimalsFemaleGene DeletionHumansMalaria VaccinesMiceNuclear ProteinsPlasmodium falciparumSporozoitesMalaria VaccinesNuclear ProteinsProtozoan Proteins

Identifiers

PMID39455824
PMCPMC11511937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.